Perkins Capital Management’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Perkins Capital Management’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-22,500	Closed	-$51K	–	150
2014 Q2	$51K	Hold	22,500	–	–	0.04%	139
2014 Q1	$68K	Hold	22,500	–	–	0.05%	129
2013 Q4	$71K	Hold	22,500	–	–	0.05%	129
2013 Q3	$62K	Sell	22,500 -285,000	-93%	-$772K	0.04%	122
2013 Q2	$766K	Buy	+307,500	New	+$1.61M	0.61%	64

Other funds holding ECTE

Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

NPC

National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Perkins Capital Management's ECTE Position: Q3 2014 in Review

Perkins Capital Management sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2014, closing a stake of 22,500 shares — an estimated $51K sold.

Perkins Capital Management first reported a position in ECTE in Q2 2013 and held it in 5 quarters. The position peaked at $766K in Q2 2013. 26 funds tracked by Wall St. Rank hold ECTE as of Q3 2014.

Perkins Capital Management reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2014 after selling out during the quarter.
Perkins Capital Management sold 22,500 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2014, an estimated $51K.
Perkins Capital Management first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 5 quarters.
Perkins Capital Management's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $766K in Q2 2013.
26 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2014.

Based on Perkins Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.